WSO - January 2023 - 13

Markus and de Leeuw
13
32. Duering M, Righart R, Csanadi E, et al. Incident subcortical
infarcts induce focal thinning in connected cortical regions.
Neurology 2012; 79: 2025-2028.
33. Ferro DA, Kuijf HJ, Hilal S, et al. Association between cerebral
cortical microinfarcts and perilesional cortical atrophy
on 3T MRI. Neurology 2022; 98: e612-e622.
34. Hilal S, Cheung CY, Wong TY, Schmetterer L and Chen C.
Retinal parameters, cortical cerebral microinfarcts, and their
interaction with cognitive impairment. Int J Stroke 2022; 18:
70-77.
35. Ohlmeier L, Nannoni S, Pallucca C, et al. Prevalence of,
and risk factors for, cognitive impairment in lacunar stroke.
Int J Stroke 2022; 18: 62-69.
36. Yu F, Wu D, Wei C and Wu A. Vascular cognitive impairment
and dementia in type 2 diabetes mellitus: an overview. Life Sci
2020; 254: 117771.
37. Biesbroek JM and Biessels GJ. Diagnosing vascular cognitive
impairment: current challenges and future perspectives. Int J
Stroke 2022; 18: 36-43.
38. Hollocks MJ, Lawrence AJ, Brookes RL, et al. Differential
relationships between apathy and depression with white matter
microstructural changes and functional outcomes. Brain
2015; 138: 3803-3815.
39. Tay J, Morris RG and Markus HS. Apathy after stroke: diagnosis,
mechanisms, consequences, and treatment. Int J Stroke
2021; 16: 510-518.
40. Lohner V, Brookes RL, Hollocks MJ, Morris RG and Markus
HS. Apathy, but not depression, is associated with executive
dysfunction in cerebral small vessel disease. PLoS ONE 2017;
12: e0176943.
41. Tay J, EFFECTS Trial Collaboration, Mårtensson B, Markus
HS and Lundström E. Does fluoxetine reduce apathetic and
depressive symptoms after stroke? An analysis of the efficacy
of fluoxetine-a randomized controlled trial in stroke trial
data set. Int J Stroke. Epub ahead of print 19 September 2022.
DOI: 10.1177/17474930221124760.
42. Skidmore ER, Whyte EM, Butters MA, Terhorst L and
Reynolds CF 3rd. Strategy training during inpatient rehabilitation
may prevent apathy symptoms after acute stroke. PM R
2015; 7: 562-570.
43. Blumen HM, Jayakody O and Verghese J. Gait in cerebral
small vessel disease, pre-dementia, and dementia: a systematic
review. Int J Stroke 2022; 18: 53-61.
44. Ibitoye RT, Castro P, Cooke J, et al. A link between frontal
white matter integrity and dizziness in cerebral small vessel
disease. NeuroImage Clin 2022; 35: 103098.
45. Cai M, Jacob MA, Norris DG, de Leeuw FE and Tuladhar
AM. Longitudinal relation between structural network efficiency,
cognition, and gait in cerebral small vessel disease. J
Gerontol A Biol Sci Med Sci 2022; 77: 554-560.
46. Wardlaw JM, Benveniste H, Nedergaard M, et al. Perivascular
spaces in the brain: anatomy, physiology and pathology. Nat
Rev Neurol 2020; 16: 137-153.
47. Yu L, Hu X, Li H and Zhao Y. Perivascular spaces, glymphatic
system and MR. Front Neurol 2022; 13: 844938.
48. Francis F, Ballerini L and Wardlaw JM. Perivascular spaces
and their associations with risk factors, clinical disorders and
neuroimaging features: a systematic review and meta-analysis.
Int J Stroke 2019; 14: 359-371.
49. Evans TE, Knol MJ, Schwingenschuh P, et al. Determinants
of perivascular spaces in the general population: a pooled
cohort analysis of individual participant data. Neurology.
Epub ahead of print 17 October 2022. DOI: 10.1212/
WNL.0000000000201349.
50. Benveniste H and Nedergaard M. Cerebral small vessel disease:
a glymphopathy? Curr Opin Neurobiol 2022; 72: 15-21.
51. Tang J, Zhang M, Liu N, et al. The association between glymphatic
system dysfunction and cognitive impairment in cerebral
small vessel disease. Front Aging Neurosci 2022; 14: 916633.
52. Leitch S, Logan M, Beishon L and Quinn TJ. International
research priority setting exercises in stroke: a systematic
review. Int J Stroke. Epub ahead of print 12 May 2022. DOI:
10.1177/17474930221096935.
53. Smith EE and Markus HS. New treatment approaches to modify
the course of cerebral small vessel diseases. Stroke 2020;
51: 38-46.
54. Sprint Mind Investigators for the SPRINT Research Group,
Nasrallah IM, Pajewski NM, et al. Association of intensive
vs standard blood pressure control with cerebral white matter
lesions. JAMA 2019; 322: 524-534.
55. Sprint Mind Investigators for the SPRINT Research Group,
Williamson JD, Pajewski NM, et al. Effect of intensive vs
standard blood pressure control on probable dementia: a randomized
clinical trial. JAMA 2019; 321: 553-561.
56. Benavente OR, Hart RG, McClure LA, et al. Effects of clopidogrel
added to aspirin in patients with recent lacunar stroke.
N Engl J Med 2012; 367: 817-825.
57. Benavente OR, Coffey CS, Conwit R, et al. Blood-pressure
targets in patients with recent lacunar stroke: the SPS3 randomised
trial. Lancet 2013; 382: 507-515.
58. Croall ID, Tozer DJ, Moynihan B, et al. Effect of standard
vs intensive blood pressure control on cerebral blood flow
in small vessel disease: the PRESERVE randomized clinical
trial. JAMA Neurol 2018; 75: 720-727.
59. Markus HS, Egle M, Croall ID, et al. PRESERVE: randomized
trial of intensive versus standard blood pressure control
in small vessel disease. Stroke 2021; 52: 2484-2493.
60. Asdaghi N, Jeerakathil T, Hameed B, et al. Oxfordshire community
stroke project classification poorly differentiates small
cortical and subcortical infarcts. Stroke 2011; 42: 2143-2148.
61. Wardlaw J, Bath PMW, Doubal F, et al. The lacunar intervention
trial 2 (LACI-2). A trial of two repurposed licenced drugs
to prevent progression of cerebral small vessel disease. Eur
Stroke J 2020; 5: 297-308.
62. Regenhardt RW, Das AS, Lo EH and Caplan LR. Advances
in understanding the pathophysiology of lacunar stroke: a
review. JAMA Neurol 2018; 75: 1273-1281.
63. Fan X, Shen W, Wang L and Zhang Y. Efficacy and safety of
DL-3-n-butylphthalide in the treatment of poststroke cognitive
impairment: a systematic review and meta-analysis. Front
Pharmacol 2022; 12: 810297.
64. Traylor M, Persyn E, Tomppo L, et al. Genetic basis of lacunar
stroke: a pooled analysis of individual patient data and
genome-wide association studies. Lancet Neurol 2021; 20:
351-361.
65. Changhe S, Mengnan G, Xiaoyan H, et al. Human blood
metabolites and lacunar stroke: a Mendelian randomization
study. Int J Stroke 2022; 18: 109-116.
International Journal of Stroke, 18(1)
WSO - January 2023

Table of Contents for the Digital Edition of WSO - January 2023
